| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |